HEADER TRANSFERASE 27-FEB-06 2G71 TITLE STRUCTURE OF HPNMT WITH INHIBITOR 3-FLUOROMETHYL-7-TRIFLUOROPROPYL- TITLE 2 THIQ AND ADOHCY COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHENYLETHANOLAMINE N-METHYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PNMTASE, NORADRENALINE N-METHYLTRANSFERASE; COMPND 5 EC: 2.1.1.28; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PNMT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PNMT-HIS KEYWDS METHYLTRANSFERASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.D.A.TYNDALL,C.L.GEE,J.L.MARTIN REVDAT 6 25-OCT-23 2G71 1 REMARK SEQADV REVDAT 5 25-APR-18 2G71 1 HETSYN REVDAT 4 13-JUL-11 2G71 1 VERSN REVDAT 3 24-FEB-09 2G71 1 VERSN REVDAT 2 09-OCT-07 2G71 1 JRNL REVDAT 1 13-FEB-07 2G71 0 JRNL AUTH C.L.GEE,N.DRINKWATER,J.D.A.TYNDALL,G.L.GRUNEWALD,Q.WU, JRNL AUTH 2 M.J.MCLEISH,J.L.MARTIN JRNL TITL ENZYME ADAPTATION TO INHIBITOR BINDING: A CRYPTIC BINDING JRNL TITL 2 SITE IN PHENYLETHANOLAMINE N-METHYLTRANSFERASE JRNL REF J.MED.CHEM. V. 50 4845 2007 JRNL REFN ISSN 0022-2623 JRNL PMID 17845018 JRNL DOI 10.1021/JM0703385 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 43749 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 4401 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3220 REMARK 3 BIN FREE R VALUE : 0.3420 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 709 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.013 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4120 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 102 REMARK 3 SOLVENT ATOMS : 275 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.14 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.99100 REMARK 3 B22 (A**2) : -6.99100 REMARK 3 B33 (A**2) : 13.98300 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.37 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.43 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 46.63 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : SAH_MOD2.PARAM REMARK 3 PARAMETER FILE 4 : 208F3_MOD.PARAM REMARK 3 PARAMETER FILE 5 : GOL.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2G71 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-MAR-06. REMARK 100 THE DEPOSITION ID IS D_1000036768. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-NOV-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ DW REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : HIRES2 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43750 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 34.960 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.520 REMARK 200 R MERGE (I) : 0.06500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.53 REMARK 200 R MERGE FOR SHELL (I) : 0.42000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1HNN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG6K, LICL, CACODYLATE, PH 5.8, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 94.09500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 47.07500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 47.07500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 141.14250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 47.07500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 47.07500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 47.04750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 47.07500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.07500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 141.14250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 47.07500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.07500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 47.04750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 94.09500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLY A 3 REMARK 465 ALA A 4 REMARK 465 ASP A 5 REMARK 465 ARG A 6 REMARK 465 SER A 7 REMARK 465 PRO A 8 REMARK 465 ASN A 9 REMARK 465 ALA A 10 REMARK 465 GLY A 11 REMARK 465 ALA A 12 REMARK 465 ALA A 13 REMARK 465 PRO A 14 REMARK 465 ASP A 15 REMARK 465 SER A 16 REMARK 465 ALA A 17 REMARK 465 PRO A 18 REMARK 465 GLY A 19 REMARK 465 GLN A 20 REMARK 465 LEU A 282 REMARK 465 GLU A 283 REMARK 465 HIS A 284 REMARK 465 HIS A 285 REMARK 465 HIS A 286 REMARK 465 HIS A 287 REMARK 465 HIS A 288 REMARK 465 HIS A 289 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 GLY B 3 REMARK 465 ALA B 4 REMARK 465 ASP B 5 REMARK 465 ARG B 6 REMARK 465 SER B 7 REMARK 465 PRO B 8 REMARK 465 ASN B 9 REMARK 465 ALA B 10 REMARK 465 GLY B 11 REMARK 465 ALA B 12 REMARK 465 ALA B 13 REMARK 465 LEU B 282 REMARK 465 GLU B 283 REMARK 465 HIS B 284 REMARK 465 HIS B 285 REMARK 465 HIS B 286 REMARK 465 HIS B 287 REMARK 465 HIS B 288 REMARK 465 HIS B 289 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 167 -72.58 -75.06 REMARK 500 CYS A 183 -68.26 -103.03 REMARK 500 THR A 264 -162.32 -106.35 REMARK 500 ASP A 267 -170.93 -173.23 REMARK 500 ASP B 101 145.95 -172.19 REMARK 500 CYS B 183 -62.12 -102.07 REMARK 500 THR B 264 -159.89 -80.47 REMARK 500 ASP B 267 -179.00 -170.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 40 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH A 2001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH B 2002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FTS A 3001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FTS B 3002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 2647 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HNN RELATED DB: PDB REMARK 900 RELATED ID: 1N7I RELATED DB: PDB REMARK 900 RELATED ID: 1N7J RELATED DB: PDB REMARK 900 RELATED ID: 1YZ3 RELATED DB: PDB REMARK 900 RELATED ID: 2G70 RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH INHIBITOR 3-HYDROXYMETHYL-7-NITRO-THIQ AND REMARK 900 ADOMET (SAM) REMARK 900 RELATED ID: 2G72 RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH INHIBITOR 3-FLUOROMETHYL-7- REMARK 900 THIOMORPHOLINOSULFONAMIDE-THIQ AND ADOMET DBREF 2G71 A 1 282 UNP P11086 PNMT_HUMAN 1 282 DBREF 2G71 B 1 282 UNP P11086 PNMT_HUMAN 1 282 SEQADV 2G71 GLU A 283 UNP P11086 EXPRESSION TAG SEQADV 2G71 HIS A 284 UNP P11086 EXPRESSION TAG SEQADV 2G71 HIS A 285 UNP P11086 EXPRESSION TAG SEQADV 2G71 HIS A 286 UNP P11086 EXPRESSION TAG SEQADV 2G71 HIS A 287 UNP P11086 EXPRESSION TAG SEQADV 2G71 HIS A 288 UNP P11086 EXPRESSION TAG SEQADV 2G71 HIS A 289 UNP P11086 EXPRESSION TAG SEQADV 2G71 GLU B 283 UNP P11086 EXPRESSION TAG SEQADV 2G71 HIS B 284 UNP P11086 EXPRESSION TAG SEQADV 2G71 HIS B 285 UNP P11086 EXPRESSION TAG SEQADV 2G71 HIS B 286 UNP P11086 EXPRESSION TAG SEQADV 2G71 HIS B 287 UNP P11086 EXPRESSION TAG SEQADV 2G71 HIS B 288 UNP P11086 EXPRESSION TAG SEQADV 2G71 HIS B 289 UNP P11086 EXPRESSION TAG SEQRES 1 A 289 MET SER GLY ALA ASP ARG SER PRO ASN ALA GLY ALA ALA SEQRES 2 A 289 PRO ASP SER ALA PRO GLY GLN ALA ALA VAL ALA SER ALA SEQRES 3 A 289 TYR GLN ARG PHE GLU PRO ARG ALA TYR LEU ARG ASN ASN SEQRES 4 A 289 TYR ALA PRO PRO ARG GLY ASP LEU CYS ASN PRO ASN GLY SEQRES 5 A 289 VAL GLY PRO TRP LYS LEU ARG CYS LEU ALA GLN THR PHE SEQRES 6 A 289 ALA THR GLY GLU VAL SER GLY ARG THR LEU ILE ASP ILE SEQRES 7 A 289 GLY SER GLY PRO THR VAL TYR GLN LEU LEU SER ALA CYS SEQRES 8 A 289 SER HIS PHE GLU ASP ILE THR MET THR ASP PHE LEU GLU SEQRES 9 A 289 VAL ASN ARG GLN GLU LEU GLY ARG TRP LEU GLN GLU GLU SEQRES 10 A 289 PRO GLY ALA PHE ASN TRP SER MET TYR SER GLN HIS ALA SEQRES 11 A 289 CYS LEU ILE GLU GLY LYS GLY GLU CYS TRP GLN ASP LYS SEQRES 12 A 289 GLU ARG GLN LEU ARG ALA ARG VAL LYS ARG VAL LEU PRO SEQRES 13 A 289 ILE ASP VAL HIS GLN PRO GLN PRO LEU GLY ALA GLY SER SEQRES 14 A 289 PRO ALA PRO LEU PRO ALA ASP ALA LEU VAL SER ALA PHE SEQRES 15 A 289 CYS LEU GLU ALA VAL SER PRO ASP LEU ALA SER PHE GLN SEQRES 16 A 289 ARG ALA LEU ASP HIS ILE THR THR LEU LEU ARG PRO GLY SEQRES 17 A 289 GLY HIS LEU LEU LEU ILE GLY ALA LEU GLU GLU SER TRP SEQRES 18 A 289 TYR LEU ALA GLY GLU ALA ARG LEU THR VAL VAL PRO VAL SEQRES 19 A 289 SER GLU GLU GLU VAL ARG GLU ALA LEU VAL ARG SER GLY SEQRES 20 A 289 TYR LYS VAL ARG ASP LEU ARG THR TYR ILE MET PRO ALA SEQRES 21 A 289 HIS LEU GLN THR GLY VAL ASP ASP VAL LYS GLY VAL PHE SEQRES 22 A 289 PHE ALA TRP ALA GLN LYS VAL GLY LEU GLU HIS HIS HIS SEQRES 23 A 289 HIS HIS HIS SEQRES 1 B 289 MET SER GLY ALA ASP ARG SER PRO ASN ALA GLY ALA ALA SEQRES 2 B 289 PRO ASP SER ALA PRO GLY GLN ALA ALA VAL ALA SER ALA SEQRES 3 B 289 TYR GLN ARG PHE GLU PRO ARG ALA TYR LEU ARG ASN ASN SEQRES 4 B 289 TYR ALA PRO PRO ARG GLY ASP LEU CYS ASN PRO ASN GLY SEQRES 5 B 289 VAL GLY PRO TRP LYS LEU ARG CYS LEU ALA GLN THR PHE SEQRES 6 B 289 ALA THR GLY GLU VAL SER GLY ARG THR LEU ILE ASP ILE SEQRES 7 B 289 GLY SER GLY PRO THR VAL TYR GLN LEU LEU SER ALA CYS SEQRES 8 B 289 SER HIS PHE GLU ASP ILE THR MET THR ASP PHE LEU GLU SEQRES 9 B 289 VAL ASN ARG GLN GLU LEU GLY ARG TRP LEU GLN GLU GLU SEQRES 10 B 289 PRO GLY ALA PHE ASN TRP SER MET TYR SER GLN HIS ALA SEQRES 11 B 289 CYS LEU ILE GLU GLY LYS GLY GLU CYS TRP GLN ASP LYS SEQRES 12 B 289 GLU ARG GLN LEU ARG ALA ARG VAL LYS ARG VAL LEU PRO SEQRES 13 B 289 ILE ASP VAL HIS GLN PRO GLN PRO LEU GLY ALA GLY SER SEQRES 14 B 289 PRO ALA PRO LEU PRO ALA ASP ALA LEU VAL SER ALA PHE SEQRES 15 B 289 CYS LEU GLU ALA VAL SER PRO ASP LEU ALA SER PHE GLN SEQRES 16 B 289 ARG ALA LEU ASP HIS ILE THR THR LEU LEU ARG PRO GLY SEQRES 17 B 289 GLY HIS LEU LEU LEU ILE GLY ALA LEU GLU GLU SER TRP SEQRES 18 B 289 TYR LEU ALA GLY GLU ALA ARG LEU THR VAL VAL PRO VAL SEQRES 19 B 289 SER GLU GLU GLU VAL ARG GLU ALA LEU VAL ARG SER GLY SEQRES 20 B 289 TYR LYS VAL ARG ASP LEU ARG THR TYR ILE MET PRO ALA SEQRES 21 B 289 HIS LEU GLN THR GLY VAL ASP ASP VAL LYS GLY VAL PHE SEQRES 22 B 289 PHE ALA TRP ALA GLN LYS VAL GLY LEU GLU HIS HIS HIS SEQRES 23 B 289 HIS HIS HIS HET SAH A2001 26 HET FTS A3001 22 HET SAH B2002 26 HET FTS B3002 22 HET GOL B2647 6 HETNAM SAH S-ADENOSYL-L-HOMOCYSTEINE HETNAM FTS (3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3, HETNAM 2 FTS 4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE HETNAM GOL GLYCEROL HETSYN FTS 3(R)-FLUOROMETHYL 7-TRIFLUOROPROPYLSULFONAMIDE 1,2,3,4- HETSYN 2 FTS TETRAHYDROISOQUINOLINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 SAH 2(C14 H20 N6 O5 S) FORMUL 4 FTS 2(C13 H16 F4 N2 O2 S) FORMUL 7 GOL C3 H8 O3 FORMUL 8 HOH *275(H2 O) HELIX 1 1 ALA A 21 TYR A 27 1 7 HELIX 2 2 GLU A 31 ALA A 41 1 11 HELIX 3 3 GLY A 52 THR A 67 1 16 HELIX 4 4 VAL A 84 LEU A 88 5 5 HELIX 5 5 LEU A 103 GLN A 115 1 13 HELIX 6 6 TRP A 123 GLY A 135 1 13 HELIX 7 7 CYS A 139 ARG A 150 1 12 HELIX 8 8 CYS A 183 SER A 188 1 6 HELIX 9 9 ASP A 190 THR A 203 1 14 HELIX 10 10 SER A 235 SER A 246 1 12 HELIX 11 11 PRO A 259 GLN A 263 5 5 HELIX 12 12 SER B 16 GLN B 28 1 13 HELIX 13 13 GLU B 31 ALA B 41 1 11 HELIX 14 14 GLY B 52 ALA B 66 1 15 HELIX 15 15 VAL B 84 LEU B 88 5 5 HELIX 16 16 SER B 89 HIS B 93 5 5 HELIX 17 17 LEU B 103 GLN B 115 1 13 HELIX 18 18 TRP B 123 GLY B 135 1 13 HELIX 19 19 CYS B 139 ARG B 150 1 12 HELIX 20 20 CYS B 183 SER B 188 1 6 HELIX 21 21 ASP B 190 THR B 203 1 14 HELIX 22 22 SER B 235 SER B 246 1 12 HELIX 23 23 PRO B 259 GLN B 263 5 5 SHEET 1 A 7 VAL A 151 PRO A 156 0 SHEET 2 A 7 ASP A 96 ASP A 101 1 N MET A 99 O ARG A 153 SHEET 3 A 7 THR A 74 ILE A 78 1 N ASP A 77 O THR A 98 SHEET 4 A 7 ALA A 175 ALA A 181 1 O VAL A 179 N ILE A 78 SHEET 5 A 7 LEU A 205 LEU A 217 1 O ILE A 214 N SER A 180 SHEET 6 A 7 GLY A 271 LYS A 279 -1 O ALA A 277 N LEU A 211 SHEET 7 A 7 TYR A 248 ILE A 257 -1 N ASP A 252 O TRP A 276 SHEET 1 B 2 TRP A 221 ALA A 224 0 SHEET 2 B 2 ALA A 227 THR A 230 -1 O LEU A 229 N TYR A 222 SHEET 1 C 7 VAL B 151 LEU B 155 0 SHEET 2 C 7 ASP B 96 THR B 100 1 N MET B 99 O ARG B 153 SHEET 3 C 7 THR B 74 ILE B 78 1 N ASP B 77 O THR B 98 SHEET 4 C 7 ALA B 175 ALA B 181 1 O VAL B 179 N ILE B 78 SHEET 5 C 7 LEU B 205 LEU B 217 1 O LEU B 212 N LEU B 178 SHEET 6 C 7 GLY B 271 LYS B 279 -1 O GLY B 271 N LEU B 217 SHEET 7 C 7 TYR B 248 ILE B 257 -1 N ASP B 252 O TRP B 276 SHEET 1 D 2 TRP B 221 ALA B 224 0 SHEET 2 D 2 ALA B 227 THR B 230 -1 O ALA B 227 N ALA B 224 SSBOND 1 CYS A 48 CYS B 139 1555 1555 2.04 SSBOND 2 CYS A 139 CYS B 48 1555 1555 2.04 CISPEP 1 PRO A 42 PRO A 43 0 0.20 CISPEP 2 LEU A 173 PRO A 174 0 -0.13 CISPEP 3 PRO B 42 PRO B 43 0 0.22 CISPEP 4 LEU B 173 PRO B 174 0 -0.30 SITE 1 AC1 20 TYR A 27 TYR A 35 TYR A 40 GLY A 79 SITE 2 AC1 20 SER A 80 GLY A 81 THR A 83 TYR A 85 SITE 3 AC1 20 ASP A 101 PHE A 102 LEU A 103 ASN A 106 SITE 4 AC1 20 ASP A 158 VAL A 159 HIS A 160 ALA A 181 SITE 5 AC1 20 PHE A 182 CYS A 183 VAL A 187 HOH A3104 SITE 1 AC2 21 TYR B 27 TYR B 35 TYR B 40 GLY B 79 SITE 2 AC2 21 SER B 80 GLY B 81 THR B 83 TYR B 85 SITE 3 AC2 21 ASP B 101 PHE B 102 LEU B 103 ASN B 106 SITE 4 AC2 21 ILE B 157 ASP B 158 VAL B 159 HIS B 160 SITE 5 AC2 21 ALA B 181 PHE B 182 CYS B 183 VAL B 187 SITE 6 AC2 21 HOH B3153 SITE 1 AC3 18 TYR A 35 ASN A 39 TYR A 40 ARG A 44 SITE 2 AC3 18 LEU A 47 VAL A 53 GLY A 54 LYS A 57 SITE 3 AC3 18 TYR A 126 PHE A 182 ALA A 186 GLU A 219 SITE 4 AC3 18 TYR A 222 MET A 258 ASP A 267 VAL A 272 SITE 5 AC3 18 HOH A3016 HOH A3120 SITE 1 AC4 14 TYR B 35 ASN B 39 TYR B 40 ARG B 44 SITE 2 AC4 14 VAL B 53 GLY B 54 LYS B 57 TYR B 126 SITE 3 AC4 14 PHE B 182 ALA B 186 GLU B 219 TYR B 222 SITE 4 AC4 14 ASP B 267 VAL B 272 SITE 1 AC5 5 ASP B 158 GLN B 161 PRO B 164 GLY B 166 SITE 2 AC5 5 HOH B3137 CRYST1 94.150 94.150 188.190 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010621 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010621 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005314 0.00000